Dr. Rushaniya Albeptovna Khairova, MD

Dr. Khairova practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Dr. Khairova's NPI, 1013243476, was assigned on October 20, 2009. Dr. Khairova holds Missouri license 2013026064.

Dr. Khairova's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Dr. Khairova's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Khairova to 3 more group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account. Dr. Khairova's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khairova practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Khairova's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Khairova is licensed in Missouri.

CMS data shows 38 Medicare services from Dr. Khairova across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $3,059 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Khairova in 2024. 73% of them have anxiety, and 70% have mood disorders. 67% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khairova's median patient age at 37, with 84% women.

In 2024, Dr. Khairova wrote 21 Medicare Part D claims. 90% of them were for generic drugs. They cover 2 drugs, with $289 in total drug cost. In 2019, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Khairova for performance year 2024, reported as part of a group. Dr. Khairova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Khairova, published from 2011 to 2025. The most frequent topics are Anxiety, Bipolar Disorder and Lithium. Dr. Khairova's most frequent co-authors are Roshan Chudal, Christopher Ignatius Gurguis and Gregory Jones.

CMS Open Payments shows 1 general payment to Dr. Khairova from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $24.